Mastalgia
Conditions
Brief summary
The main objective of this study is to determine the effectiveness of transcutaneous electrical nerve stimulation (TENS) treatment on pain and quality of life in mastalgia, which treatment has not yet reached a consensus.
Detailed description
The main objective of this study is to determine the effectiveness of transcutaneous electrical nerve stimulation (TENS) treatment on pain and quality of life in mastalgia, which treatment has not yet reached a consensus. This randomized controlled clinical trial was completed with 20 women suffering from mastalgia. Patients were randomly assigned to the TENS treatment and sham application groups. Pain intensity, pain patterns and quality of life were evaluated with Breast Pain and SF-36 questionnaires before and 10 days after treatment in all patients.
Interventions
DEVICETENS
Transcutaneous electrical nerve stimulation (TENS) is a non-invasive treatment method widely used for pain control
Sponsors
Ankara University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
* Patients with mastalgia between 18 and 70 yrs old
Exclusion criteria
* Previous or new diagnosis of diseases that may cause extramammary mastalgia (history of previous breast surgery; inflammatory and/or tumoral breast or chest disorders such as mastitis, fibrocystic breasts, breast cancer or chest malignancies etc.) * Having with conditions that might prevent TENS application (pacemaker, metal prosthesis, epilepsy, etc.) * Being unable or insufficient to fill the questionnaires.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain intensity | Before and 10 days after treatment | The Breast Pain Questionnaire (BPQ), derived from the McGill Pain Questionnaire, was used to assess breast pain intensity. It is a tool that aims to evaluate the severity, pattern, location, duration and frequency of breast pain. It is calculated on the basis of Visual analog scale (VAS) and present pain intensity (PPI) scores in addition to sensory and affective component scores. Regarding the final total BPQ scores, patients' pain severity classified as mild (0-100), moderate (100-200), and severe (\>200) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Quality of life | Before and 10 days after treatment | The Turkish version of the Short Form-36 version 2 (SF-36v2) was used to assess QoL before and 10 days after treatment. |
Countries
Turkey (Türkiye)
Outcome results
None listed